REAL-WORLD DATA IN VERY YOUNG NON-METASTATIC BREAST CANCER: SINGLE INSTITUTION EXPERIENCE

Real World ◽

Metastatic Breast ◽

Single Institution ◽

Real World Data ◽

Abstract P6-16-04: Real World data and patterns of care of metastatic breast cancer (MBC) in Brazil: First results of LACOG 0312 retrospective study

10.1158/1538-7445.sabcs16-p6-16-04 ◽

2017 ◽

Author(s):

CH Barrios ◽

D Uema ◽

E Cronenberger ◽

V Lima ◽

J Bines ◽

...

Keyword(s):

Breast Cancer ◽

Retrospective Study ◽

Real World ◽

Metastatic Breast ◽

Patterns Of Care ◽

Real World Data ◽

World Data ◽

First Results

Real‐world data of lapatinib and treatment after lapatinib in patients with previously treated HER2‐positive metastatic breast cancer: A multicenter, retrospective study

Cancer Medicine ◽

10.1002/cam4.2943 ◽

2020 ◽

Vol 9 (9) ◽

pp. 2981-2988

Author(s):

Yizhao Xie ◽

Rui Ge ◽

Die Sang ◽

Ting Luo ◽

Wei Li ◽

...

Keyword(s):

Breast Cancer ◽

Retrospective Study ◽

Real World ◽

Metastatic Breast ◽

Her2 Positive ◽

Real World Data ◽

World Data ◽

Previously Treated

55P Eribulin in heavily pretreated metastatic breast cancer: A real-world data from India

Annals of Oncology ◽

10.1016/j.annonc.2020.10.075 ◽

2020 ◽

Vol 31 ◽

pp. S1264

Author(s):

T.K. Mandal ◽

J. Bajpai ◽

A. Kapoor ◽

A. Kumar ◽

J. Ghosh ◽

...

Keyword(s):

Breast Cancer ◽

Real World ◽

Metastatic Breast ◽

Real World Data ◽

World Data ◽

Heavily Pretreated

Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study

Frontiers in Oncology ◽

10.3389/fonc.2020.00271 ◽

2020 ◽

Vol 10 ◽

Author(s):

Yi Li ◽

Chengcheng Gong ◽

Qianyi Lu ◽

Zhaochun Zhou ◽

Ting Luo ◽

...

Keyword(s):

Breast Cancer ◽

Retrospective Study ◽

Real World ◽

Metastatic Breast ◽

Her2 Positive ◽

Real World Data ◽

Real world data in luminal like de novo metastatic breast cancer following guidelines recommendations.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e13029 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e13029-e13029

Author(s):

Fernando Pikabea ◽

Borja Lopez De San Vicente ◽

Elena Galve Calvo ◽

Juan Fernando Arango ◽

Ane Zumarraga ◽

...

Keyword(s):

Breast Cancer ◽

Real World ◽

De Novo ◽

Metastatic Breast ◽

Real World Data ◽

REAL WORLD DATA ON PATIENT PROFILES AND PATTERNS OF CARE IN DE NOVO METASTATIC BREAST CANCER: AN ANALYSIS OF 17 YEARS (1995–2011)

10.29289/259453942019v29s1cp06 ◽

2019 ◽

Author(s):

Leonardo R. Soares ◽

◽

Ruffo Freitas- Junior ◽

Rodrigo D. Nunes ◽

Edesio Martins ◽

...

Keyword(s):

Breast Cancer ◽

Real World ◽

De Novo ◽

Metastatic Breast ◽

Patterns Of Care ◽

Real World Data ◽

World Data ◽

Patient Profiles

Abstract PS10-55: Palbociclib real-world data in metastatic breast cancer: A multi-site report of survival and adverse events in routine clinical practice in Scotland

10.1158/1538-7445.sabcs20-ps10-55 ◽

2021 ◽

Author(s):

Ailsa J Oswald ◽

Peter Hall ◽

Arran Turnbull ◽

Olga Oikonomidou

Keyword(s):

Breast Cancer ◽

Clinical Practice ◽

Adverse Events ◽

Real World ◽

Metastatic Breast ◽

Routine Clinical Practice ◽

Real World Data ◽

Real world data on use of palbociclib in hormone-receptor (ER) positive HER2 negative metastatic breast cancer (MBC) among Asian patients

Annals of Oncology ◽

10.1093/annonc/mdx654.024 ◽

2017 ◽

Vol 28 ◽

pp. x33-x34

Author(s):

J. Chiu ◽

R. Leung ◽

H. Sze ◽

P. Teo ◽

P. Choi ◽

...

Keyword(s):

Breast Cancer ◽

Real World ◽

Hormone Receptor ◽

Metastatic Breast ◽

Real World Data ◽

World Data ◽

Asian Patients ◽

Er Positive

Real world data on first-line systemic therapy for hormone receptor positive HER2 negative metastatic breast cancer: a trend shift in the era of CDK 4/6 inhibitors

Clinical Breast Cancer ◽

10.1016/j.clbc.2021.04.003 ◽

2021 ◽

Author(s):

Gustavo Werutsky ◽

Tomás Reinert ◽

Mahira Lopes Rosa ◽

Carlos Henrique Barrios

Keyword(s):

Breast Cancer ◽

Real World ◽

Systemic Therapy ◽

Hormone Receptor ◽

Metastatic Breast ◽

First Line ◽

Real World Data ◽

World Data ◽

Hormone Receptor Positive

Real world data: Trastuzumab w/o concurrent endocrine therapy in luminal HER2-positive metastatic breast cancer resulted in decreased overall survival

European Journal of Cancer ◽

10.1016/s0959-8049(18)30561-6 ◽

2018 ◽

Vol 92 ◽

pp. S112

Author(s):

S. Susnjar ◽

L. Popovic ◽

A. Cvetanovic ◽

N. Stanic ◽

J. Citic ◽

...

Keyword(s):

Breast Cancer ◽

Overall Survival ◽

Endocrine Therapy ◽

Real World ◽

Metastatic Breast ◽

Her2 Positive ◽

Real World Data ◽